These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 20332125

  • 21. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
    Kim SD, Kang W, Lee HW, Park DJ, Ahn JH, Kim MJ, Kim EY, Kim SW, Nam HS, Na HJ, Yoon YR.
    Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
    [Abstract] [Full Text] [Related]

  • 22. Bioequivalence study with two different oral formulations of methocarbamol in healthy subjects. A mono-centre, comparative, randomized, open-label, single-dose, 2-way crossover study.
    Schlegelmilch R, Eydeler AU, Barkworth M, Radeke A.
    Arzneimittelforschung; 2009 Apr; 59(5):238-42. PubMed ID: 19537524
    [Abstract] [Full Text] [Related]

  • 23. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
    Boonleang J, Panrat K, Tantana C, Krittathanmakul S, Jintapakorn W.
    Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effect of switching recombinant human growth hormone: Comparative analysis of phase 3 clinical data.
    Romer T, Zabransky M, Walczak M, Szalecki M, Balser S.
    Biol Ther; 2011 Apr; 1(1):5. PubMed ID: 24392295
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Intranasal Human Growth Hormone (hGH) Induces IGF-1 Levels Comparable With Subcutaneous Injection With Lower Systemic Exposure to hGH in Healthy Volunteers.
    Lewis AL, Jordan F, Patel T, Jeffery K, King G, Savage M, Shalet S, Illum L.
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4364-71. PubMed ID: 26425883
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A first-in-man phase 1 trial for long-acting TransCon Growth Hormone.
    Gilfoyle D, Mortensen E, Christoffersen ED, Leff JA, Beckert M.
    Growth Horm IGF Res; 2018 Apr; 39():34-39. PubMed ID: 29273485
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics and pharmacodynamics of a new formulation of recombinant human growth hormone administered by ZomaJet 2 Vision, a new needle-free device, compared to subcutaneous administration using a conventional syringe.
    Agersø H, Møller-Pedersen J, Cappi S, Thomann P, Jesussek B, Senderovitz T.
    J Clin Pharmacol; 2002 Nov; 42(11):1262-8. PubMed ID: 12412826
    [Abstract] [Full Text] [Related]

  • 32. A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles.
    Wei Y, Wang Y, Kang A, Wang W, Ho SV, Gao J, Ma G, Su Z.
    Mol Pharm; 2012 Jul 02; 9(7):2039-48. PubMed ID: 22663348
    [Abstract] [Full Text] [Related]

  • 33. Abuse of recombinant human growth hormone: studies in two different dog models.
    Rigamonti AE, Scanniffio D, Bonomo SM, Cella SG, Sartorio A, Müller EE.
    Neuroendocrinology; 2004 Jul 02; 79(5):237-46. PubMed ID: 15218318
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Comparative bioavailability study of triflusal oral solution vs. triflusal capsules in healthy subjects. A single, randomized, two-way cross-over, open-label phase I study.
    Izquierdo I, Borja J, Rovira S, Pelagio P, Torres F, Cebrecos J, García-Rafanell J.
    Arzneimittelforschung; 2010 Jul 02; 60(1):36-41. PubMed ID: 20184225
    [Abstract] [Full Text] [Related]

  • 37. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.
    Spínola AC, Almeida S, Filipe A, Neves R, Trabelsi F, Farré A.
    Clin Ther; 2009 Sep 02; 31(9):1992-2001. PubMed ID: 19843489
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers.
    Iqbal M, Khuroo A, Batolar LS, Tandon M, Monif T, Sharma PL.
    Clin Ther; 2010 Mar 02; 32(3):588-96. PubMed ID: 20399995
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.